J.B. Cabezuelo

ORCID: 0000-0001-7523-9962
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Transplantation Techniques and Outcomes
  • Renal Diseases and Glomerulopathies
  • Liver Disease Diagnosis and Treatment
  • Renal Transplantation Outcomes and Treatments
  • Xenotransplantation and immune response
  • Liver Disease and Transplantation
  • Muscle and Compartmental Disorders
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Dialysis and Renal Disease Management
  • Central Venous Catheters and Hemodialysis
  • Genetic and Kidney Cyst Diseases
  • Vasculitis and related conditions
  • Potassium and Related Disorders
  • Parathyroid Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Vascular Procedures and Complications
  • Sarcoidosis and Beryllium Toxicity Research
  • Vascular anomalies and interventions
  • Liver Diseases and Immunity
  • Neurological and metabolic disorders
  • Animal Genetics and Reproduction
  • Biomedical Research and Pathophysiology
  • Renal and related cancers
  • Tuberous Sclerosis Complex Research
  • Health and Medical Education

Hospital Universitario Virgen de la Arrixaca
2000-2025

Hospital Reina Sofía de Murcia
2012-2021

Hospital Universitario Reina Sofía
2010-2021

Central University of Ecuador
2017

Hospital General Universitario Santa María del Rosell
2006

Santa Lucía University General Hospital
2006

Hospital General Universitario de Elche
1991-2003

Pediatric Nephrology of Alabama
1991-2000

University of Alicante
1991

Background. It is not known whether the pig liver capable of functioning efficiently when transplanted into a primate, neither there experience in transplanting from transgenic pigs expressing human complement regulator decay accelerating factor (h-DAF) baboon. The objective this study was to determine porcine would support metabolic functions non-human primates and establish effect hDAF expression prevention hyperacute rejection livers primates. Methods. Five orthotopic xenotransplants...

10.1097/00007890-200010150-00001 article EN Transplantation 2000-10-01

Abstract Diabetic nephropathy is the most important cause of renal failure worldwide and characterized by sustained inflammation regulated in part NLRP3 Inflammasome. Attenuation a major priority to prevent damage. Our previous publications show that DJ-1 has antioxidant anti-inflammatory properties kidney. ND-13 short peptide consisting 13 amino acids DJ-1-protein, which could increase pathway activation. The aim these studies was determine role pathogenesis diabetic study possible...

10.1101/2025.01.21.633908 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-01-23

Abstract Background Some 7-10% of patients on replacement renal therapy (RRT) are receiving it because autosomal dominant polycystic kidney disease (ADPKD). The age at initiation RRT is expected to increase over time. Methods Clinical data 1,586 (7.9%) with ADPKD and 18,447 (92.1%) other nephropathies were analysed from 1984 through 2009 (1984–1991, 1992–1999 2000–2009). Results remained stable the three periods in group (56.7 ± 10.9 (mean SD) vs 57.5 12.1 57.8 13.3 years), whereas increased...

10.1186/1471-2369-14-186 article EN cc-by BMC Nephrology 2013-09-05

To report a case of Henoch-Schönlein purpura that appears to be related the intake clarithromycin for pharyngitis/tonsillitis.We describe associated with therapy in 48-year-old white man no history allergic drug reactions. Four days after starting therapy, he came our hospital emergency room because non-pruritic palpable purpuric rash on trunk and extremities arthralgias involving elbows knees. Administration was suspended, few days, skin lesions quickly resolved. Three weeks later, patient...

10.5414/cpp41213 article EN International Journal of Clinical Pharmacology and Therapeutics 2003-05-01

Abstract Expanded hemodialysis (HDx), using medium cut‐off membrane, is a novel therapy that effectively clears middle molecules (MMs). We aimed to compare HDx hemodiafiltration (HDF) in an open randomized clinical study. Patients currently on HDF (age 18–80 years; >3 months) were switch ( N = 21) or continue 22) with 24‐week follow‐up. Pre‐ post‐dialysis reduction ratios (RR) and changes pre‐dialysis levels over time evaluated for MMs biomarkers. Use of erythropoiesis‐stimulating agents...

10.1111/1744-9987.13700 article EN Therapeutic Apheresis and Dialysis 2021-06-14
Carles Forné Serafí Cambray Marcelino Bermúdez-López Elvira Fernández Milica Božić and 95 more José Manuel Valdivielso José Regidor Jaume Almirall Esther Ponz Jesús Arteaga Coloma Auxiliadora Bajo Rubio Raquel Díaz Montserrat Belart Rodríguez Antonio Gascón Jordi Bover Sanjuán Josep Bronsoms Artero J.B. Cabezuelo Jesús Calviño Varela Pilar Caro Acevedo Jordi Carreras Bassa Aleix Cases Elisabet Massó Jiménez Rosario Moreno López Secundino Cigarrán Saray López Prieto Lourdes Comas Mongay Isabel Comerma Teresa Compte Jové Marta Cuberes Izquierdo Fernando de Álvaro Covadonga Hevia Ojanguren Gabriel de Arriba Dolores del Pino Rafael Diaz-Tejeiro Izquierdo Francisco Ahijado Hormigos Marta Dotori Verónica Duarte Sara Estupiñan Torres José Fernández Reyes Loreto Fernández Rodríguez Guillermina Fernández Antonio Galán Serrano César García Cantón Antonio Luis García Herrera Mercedes García Mena Luis Gil Sacaluga María Aguilar José Luis Górriz Emma Huarte Loza José Luis Lerma A. Cañada Jesús Pedro Marín Álvarez Nàdia Martín Alemany Jesús Martín García Alberto Martínez Castelao María Martínez Villaescusa Isabel Martínez Itsaso Larrabide Eguren Silvia Moreno Los Huertos Ricardo Mouzo Mirco Antonia Munar Vila Ana Beatriz Muñoz Díaz Juan F. González Javier Nieto Agustín Carreño Enrique Novoa Fernández Alberto Ortíz Beatriz Fernández Vicente Paraíso Miguel Pérez Fontán Ana Peris Domingo Celestino Piñera Haces D. Garrido Mario Prieto Velasco Carmina Puig Marí Maite Rivera Eduardo Rubio González M. Pilar Ruiz Mercedes Salgueira Lazo Ana Isabel Martínez Puerto José Antonio Sánchez Tomero José Emilio Hernández Sánchez Ramon Sans Lorman Ramón Saracho Maria‐Rosa Sarrias Daniel Serón María José Soler Clara Barrios Fernando Henrique Sousa D Torán Fernando Tornero Molina José Javier Usón Carrasco Ildefonso Valera Cortes Merce Vilaprinyo del Perugia Rafael C Virto Ruiz Vicente Pallarés‐Carratalá C. Santos Altozano Miguel Artigao Ródenas Inés Gil Gil Francisco Adan Gil

Abstract Background Chronic kidney disease (CKD) patients show an increased burden of atherosclerosis and high risk cardiovascular events (CVEs). There are several biomarkers described as being associated with CVEs, but their combined effectiveness in stratification CKD has not been tested. The objective this work is to analyse the ability 19 atheromatous predicting CVEs after 4 years follow-up a subcohort NEFRONA study individuals different stages without previous CVEs. Methods Nineteen...

10.1093/ckj/sfz094 article EN cc-by-nc Clinical Kidney Journal 2019-07-08
José Manuel Valdivielso Sol Carriazo Marisa Martín Beatriz Fernández‐Fernández Marcelino Bermúdez-López and 90 more Alberto Ortíz A Provencio Regidor Jaume Almirall Esther Ponz Arteaga Coloma M. Auxiliadora Bajo Díaz Ma Auxiliadora Montserrat Belart Rodríguez Antonio Gascón Jordi Bover Sanjuán Josep Bronsoms Artero J.B. Cabezuelo Salomé Muray Cases Jesús Calviño Varela Pilar Caro Acevedo Jordi Carreras Bassa Aleix Cases Elisabet Massó Jiménez Rosario Moreno López Secundino Cigarrán Saray López Prieto Lourdes Comas Mongay Isabel Comerma Ma Teresa Compte Jové Marta Cuberes Izquierdo Fernando de Álvaro Covadonga Hevia Ojanguren Gabriel de Arriba María Dolores del Pino y Pino Rafael Diaz-Tejeiro Izquierdo Marta Dotori Verónica Duarte Sara Estupiñan Torres María José Fernández‐Reyes Ma Loreto Fernández Rodríguez Guillermina Fernández Antonio Galán Serrano César García Cantón Antonio Luis García Herrera Mercedes García Mena Luis Gil Sacaluga María Aguilar José Luis Górriz Emma Huarte Loza José Luis Lerma A. Cañada Jesús Pedro Marín Álvarez Nàdia Martín Alemany Jesús Martín García Alberto Martínez Castelao María Martínez Villaescusa Isabel Martínez Itsaso Larrabide Eguren Silvia Moreno Los Huertos Ricardo Mouzo Mirco Antonia Munar Vila Ana Beatriz Muñoz Díaz Juan F. Navarro‐González Javier Nieto Agustín Carreño Enrique Novoa Fernández Alberto Ortíz Beatriz Fernández Vicente Paraíso Miguel Pérez Fontán Ana Peris Domingo Celestino Piñera Haces Ma Dolores Prados Garrido Mario Prieto Velasco Carmina Puig Marí Maite Rivera Eduardo Rubio González M. Pilar Ruiz Mercedes Salgueira Lazo Ana Isabel Martínez Puerto José Antonio Sánchez Tomero José Emilio Hernández Sánchez Ramon Sans Lorman Ramón Saracho Maria‐Rosa Sarrias Daniel Serón María José Soler Clara Barrios Fernando Henrique Sousa D Torán Fernando Tornero Molina José Javier Usón Carrasco Ildefonso Valera Cortes Ma Merce Vilaprinyo del Perugia Rafael C Virto Ruiz

Hyperkalemia is common among patients with chronic kidney disease (CKD) but there scarce information on differential risk factors and outcomes for men women. For instance, smoking has been suggested to be a factor hyperkalemia, specific analysis of the sex-specific impact hyperkalemia in CKD lacking. We studied serum potassium levels 2891 participants from NEFRONA cohort: 483 controls (47% women) 2408 (38% without prior cardiovascular (CVD), assessing whether if associated separately Median...

10.1093/ckj/sfad212 article EN cc-by-nc Clinical Kidney Journal 2023-10-09

A 74-year-old woman developed acute renal failure and granulomatous interstitial nephritis associated with hydrochlorothiazide/amiloride. On stopping the drug function improved, but not significantly. Around 20 months after prednisone administration, had stabilized, a moderate degree of insufficiency. The case is discussed, some aspects induced by diuretics are briefly reviewed.

10.1159/000168845 article EN American Journal of Nephrology 1995-01-01

El objetivo del estudio fue analizar las FAV-RC en prediálisis que se hizo un seguimiento clínico y ecográfico de la maduración cuyo fracaso trató. Estudiamos 127 117 pacientes prediálisis. Todos disponían mapa preoperatorio. La era madura si tenía flujo arteria humeral ≥500 ml/min diámetro vena cefálica ≥4 mm. Se trató el según tipo lesión. Un total 58 iniciaron hemodiálisis durante seguimiento. En 106 funcionantes, 72 (68%) fueron maduras 34 (32%) inmaduras. 97% inmaduras presentaron al...

10.1016/j.nefro.2015.10.016 article ES cc-by-nc-nd Nefrología 2016-03-02
Coming Soon ...